Basaglar KwikPen

Basaglar KwikPen Caution For Usage

insulin glargine

Manufacturer:

Eli Lilly

Distributor:

Zuellig
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Caution For Usage
Major Incompatibilities: This medicinal product must not be mixed with other medicinal products.
Special precautions for disposal and other handling: Insulin Glargine (Basaglar) must not be mixed with any other insulin or medicinal product or diluted. Mixing or diluting can change its time/action profile and mixing can cause precipitation.
Insulin Glargine (Basaglar KwikPen): Inspect the cartridge before use. It must only be used if the solution is clear, colorless, with no solid particles visible, and if it is of water-like consistency. Since Insulin Glargine (Basaglar) is a solution, it does not require re-suspension before use.
Insulin Glargine (Basaglar) must not be mixed with any other insulin or diluted. Mixing or diluting can change its time/action profile and mixing can cause precipitation.
Empty pens must never be reused and must be properly discarded.
To prevent the possible transmission of disease, each pen must be used by one patient only.
Insulin label must always be checked before each injection to avoid medication errors between Insulin Glargine (Basaglar) and other insulins (see Precautions).
Handling of the pen: The patient should be advised to read the instructions for use included in the package leaflet carefully before using Insulin Glargine (Basaglar KwikPen).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in